Intracranial Hemorrhage, Hypertensive
8
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
25%
2 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Comparison of Post-Craniotomy Blood Pressure Targets
Ketamine for Sedation in Severe Traumatic Brain Injury
Multiomic Analysis of Traumatic Brain Injury and Hypertension Intracranial Hemorrhage Lesion Tissue
Minimally-invasive Surgery Versus Craniotomy in Patients With Supratentorial Hypertensive Intracerebral Hemorrhage
Start or STop Anticoagulants Randomised Trial (SoSTART)
MRI for the Early Evaluation of Acute Intracerebral Hemorrhage
Neurological Outcomes of Primary Intracerebral Haemorrhage
Intravenous Immunoglobulin for Acute Intracranial Hemorrhage